Illumina has entered a molecular diagnostics partnership with Kindstar Global, a provider of testing services in China. The deal calls for the companies to launch molecular diagnostic assays that use Illumina's TruSight sets for next-generation sequencing, NuPCR reagents for qPCR and the Infinium Dx CytoSNP-12 BeadChip test at Kindstar's laboratories.

Related Summaries